ARTICLES BY THIS AUTHOR
- 4/5/2024
Topiramate use during pregnancy has minimal effect on autism risk in children
Large study compares risk of autism spectrum disorder in offspring when topiramate, valproate or lamotrigine were taken during pregnancy. - 4/2/2024
Help patients get ready to safely view the April 8 solar eclipse
Even a brief look at the Sun during a full or partial eclipse can result in temporary or permanent damage to the eyes if proper precautions are not taken. - 4/2/2024
Each Mirena intrauterine system now provides conception control for up to 8 years
Health Canada extends the time period for use of a single Mirena intrauterine system for conception control from five years to eight years. - 3/27/2024
POP QUIZ: Measles
Canada is seeing an increase in measles activity in 2024 compared to 2023. Which statement about measles is false? - 3/26/2024
First once-weekly basal insulin is now approved in Canada
With its reduced injection frequency, insulin icodec (Awiqli) has the potential to provide better adherence and greater treatment satisfaction in some patients. - 3/22/2024
U.S. guidelines focus on topical therapies for vitiligo in children and young adults
Guidelines and expert consensus-based recommendations for the diagnosis and treatment of vitiligo in young patients. - 3/19/2024
Updated recommendations for use of pneumococcal vaccines in children
National Advisory Committee on Immunization issues guidance on 15-valent and 20-valent conjugate pneumococcal vaccines for preventing invasive pneumococcal disease. - 3/15/2024
A refresher on recognizing and treating measles
Spring-break travel, a global rise in measles cases and reduced measles vaccine coverage among school-aged children in Canada could lead to a rise in cases in Canada. - 3/14/2024
POP QUIZ: New treatment for alopecia areata
Can you tell which statement about Litfulo (ritlecitinib), the new prescription drug for treatment of severe alopecia areata, is false? - 3/12/2024
Updated guidance on the use of the protein subunit XBB.1.5 COVID-19 vaccine
National Advisory Committee on Immunization issues updated recommendations for use of Novavax’s Nuvaxovid XBB.1.5 COVID-19 vaccine.